Inflammation is hypothesized to play a significant role in the development of type 2 diabetes; however, reports on clinical inflammatory conditions are limited. Studies have suggested that periodontitis affects glucose control in diabetics. This community-based study examined the relationship between periodontitis and glucose tolerance status, including changes in status. The relationship between periodontal condition and the results of a 75-g oral glucose tolerance test was examined in 961 adults in 1998. Deep pockets (mean pocket depth > 2.0 mm) were significantly associated with impaired glucose tolerance and with diabetes as compared with shallow pockets (< 1.3 mm). In the subgroup with normal glucose tolerance 10 years previously, subjects who subsequently developed impaired glucose tolerance were significantly more likely to have deep pockets. Deep pockets were closely related to current glucose tolerance status and the development of glucose intolerance.
Get full access to this article
View all access options for this article.
References
1.
Albandar JM, Brunelle JA, Kingman A (1999). Destructive periodontal disease in adults30 years of age and older in the United States, 1988–1994. J Periodontol 70:13–29.
2.
Alberti KG, Zimmet PZ (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med15:539–553.
3.
Brown LJ, Brunelle JA, Kingman A (1996). Periodontal status in the United States, 1988–1991: prevalence, extent, and demographic variation. J Dent Res75(Spec Iss):672–683.
4.
Collin HL, Uusitupa M, Niskanen L, Kontturi-Närhi V, Markkanen H, Koivisto AM, et al. (1998). Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol69:962–966.
5.
Festa A, D’Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM (2000). Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation102:42–47.
6.
Genco R, Offenbacher S, Beck J (2002). Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms. J Am Dent Assoc133(Suppl):14S–22S.
7.
Glurich I, Grossi S, Albini B, Ho A, Shah R, Zeid M, et al. (2002). Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol9:425–432.
8.
Grossi SG (2001). Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann Periodontol6:138–145.
9.
Grossi SG, Skrepcinski FB, DeCaro T, Robertson DC, Ho AW, Dunford RG, et al. (1997). Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol68:713–719.
10.
Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med345:790–797.
11.
Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, et al. (2001). The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol72:774–778.
12.
Kubo M, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Hirakata H, et al. (1999). Effect of hyperinsulinemia on renal function in a general Japanese population: the Hisayama study. Kidney Int55:2450–2456.
13.
Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U (2000). Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol71:1528–1534.
14.
Miller LS, Manwell MA, Newbold D, Reding ME, Rasheed A, Blodgett J, et al. (1992). The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. J Periodontol63:843–848.
15.
Nishimura F, Taniguchi A, Iwamoto Y, Soga Y, Fukushima M, Nagasaka S, et al. (2002). Porphyromonas gingivalis infection is associated with elevated C-reactive protein in nonobese Japanese type 2 diabetic subjects (letter). Diabetes Care25:1888.
16.
Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E (2001). Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol72:1221–1227.
17.
Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS (1997). Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 200014:216–248.
18.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc286:327–334.
19.
Saito T, Murakami M, Shimazaki Y, Oobayashi K, Matsumoto S, Koga T (2003). Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J Periodontol74:1741–1746.
20.
Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS (2000). Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res79:49–57.
21.
Stewart JE, Wager KA, Friedlander AH, Zadeh HH (2001). The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol28:306–310.
22.
Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997). Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature389:610–614.
23.
Wakai K, Kawamura T, Umemura O, Hara Y, Machida J, Anno T, et al. (1999). Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol26:664–672.
24.
Williams RCJ, Mahan CJ (1960). Periodontal disease and diabetes in young adults. J Am Med Assoc172:776–778.
25.
Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT (2000). Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol151:273–282.
26.
Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG (1999). Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab84:272–278.
